Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda

• Hoofdauteurs: Jonathan Kitonsa (Auteur), Abu-Baker Ggayi (Auteur), Zacchaeus Anywaine (Auteur), Eva Kisaakye (Auteur), Laura Nsangi (Auteur), Vincent Basajja (Auteur), Mary Nyantaro (Auteur), Deborah Watson-Jones (Auteur), Georgi Shukarev (Auteur), Ine Ilsbroux (Auteur), Cynthia Robinson (Auteur), Pontiano Kaleebu (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2020-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background The 2013-2016 Ebola epidemic in West Africa is the worst ever caused by Ebolaviruses with over 28,000 human cases and 11,325 deaths. The World Health Organisation (WHO) declared the epidemic a public health crisis that required accelerated development of novel interventions including vacc...